Facebook Q&A on Electroconvulsive Therapy – March 17

Having trouble viewing this email? View it as a Web page.

NIMH Banner


Despite electroconvulsive therapy’s (ECT) strong efficacy and safety record, many misconceptions still persist among both patients and professionals. Although major depression is one of the most common mental disorders in the U.S., some patients don’t respond to the most commonly used treatments. ECT is often the last best hope. 

In recognition of Brain Awareness Week  (BAW), please join the National Institute of Mental Health (NIMH) on Thursday, March 17, 2016, for a live Facebook Q&A on ECT. Expert Sarah Hollingsworth Lisanby, M.D., will be debunking ECT myths and answering your questions. The Q&A will occur on NIMH’s Facebook page. Please bring your questions! 


Facebook Q&A on ECT